Abstract
Purpose
To examine the difference in hematological data and postsurgical course after esophagectomy between patients receiving preoperative chemoradiation and patients without preoperative treatment.
Methods
Twenty-two patients with squamous cell carcinoma of the esophagus who underwent esophagectomy during the past 2 years were retrospectively analyzed in the study. Six patients had preoperative chemoradiation (CRT group) and 16 patients had no preoperative treatment (non-CRT group). The hematological data, postoperative course, and surgical complications were compared between the two groups.
Results
Patients in the CRT group were given cisplatin and 5-FU (143 and 6,000 mg on average, respectively) plus an average of 35 Gy of radiation. Although the neutrophil count did not show a significant difference between the two groups, the band cell count was lower in the CRT group compared with the non-CRT group on postoperative day 1 (P<0.05). Postoperative pneumonia was detected in three patients (50%) from the CRT group versus none of the non-CRT group.
Conclusion
Preoperative CRT may be a risk factor for postoperative pneumonia in patients with esophageal carcinoma who undergo esophagectomy. The normal bone marrow response of releasing band cells from the postmitotic marrow pool after surgery could be disturbed by CRT, which might contribute to an increase in later pulmonary complications.
Similar content being viewed by others
References
Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185(6):538–543
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232
Collard JM, Kestens PJ (1993) 5-Year survival after subtotal extensive esophagectomy for cancer. Chirurgie 119(9):558–563
Lerut T, Coosemans W, De Leyn P et al (1999) Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. Hepatogastroenterology 46(26):717–725
Nigro JJ, DeMeester SR, Hagen JA et al (1999) Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 117(5):960–968
Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J (2001) Analysis of reduced death and complication rates after esophageal resection. Ann Surg 233(3):338–344
Orringer MB, Marshall B, Iannettoni MD (1999) Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 230(3):392–400
Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW (2001) Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 181(5):440–444
Liao Z, Zhang Z, Jin J et al (2004) Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484–1493
Noguchi T, Moriyama H, Wada S et al (2003) Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus 16(2):94–98
Lew JI, Gooding WE, Ribeiro U Jr, Safatle-Ribeiro AV, Posner MC (2001) Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg 136(7):737–742
Urschel JD, Ashiku S, Thurer R, Sellke FW (2003) Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer—a review. Dis Esophagus 16(2):60–65
Bosset JF, Lorchel F, Mantion G et al (2005) Radiation and chemoradiation therapy for esophageal adenocarcinoma. J Surg Oncol 92(3):239–245
Heidecke CD, Weighardt H, Feith M et al (2002) Neoadjuvant treatment of esophageal cancer: immunosuppression following combined radiochemotherapy. Surgery 132(3):495–501
Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR (1995) Multimodal treatment for squamous cell esophageal cancer. World J Surg 19(2):198–204
Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE (2002) Pulmonary complications after esophagectomy. Ann Thorac Surg 73(3):922–926
Wang SL, Liao Z, Vaporciyan AA et al (2006) Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692–699
Lee HK, Vaporciyan AA, Cox JD et al (2003) Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose–volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317–1322
Urschel JD, Sellke FW (2003) Complications of salvage esophagectomy. Med Sci Monit 9(7):RA173–RA180
Swisher SG, Wynn P, Putnam JB et al (2002) Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175–183
Sato Y, van Eeden SF, English D, Hogg JC (1998) Bacteremic pneumococcal pneumonia: bone marrow release and pulmonary sequestration of neutrophils. Crit Care Med 26(3):501–509
van Eeden SF, Hogg JC (2000) The response of human bone marrow to chronic cigarette smoking. Eur Respir J 15(5):915–921
Mukae H, Hogg JC, English D, Vincent R, van Eeden SF (2000) Phagocytosis of particulate air pollutants by human alveolar macrophages stimulates the bone marrow. Am J Physiol Lung Cell Mol Physiol 279(5):L924–L931
Kelley ST, Coppola D, Karl RC (2004) Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 8(3):227–231
Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337(3):161–167
Adelstein DJ, Rice TW, Becker M et al (1997) Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 80(6):1011–1020
Marsh JC, Boggs DR, Cartwright GE, Wintrobe MM (1967) Neutrophil kinetics in acute infection. J Clin Invest 46(12):1943–1953
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suwa, T., Kitagawa, Y., Sasaki, T. et al. Release of band cells from the bone marrow is impaired by preoperative chemoradiation in patients with esophageal carcinoma: increased risk of postoperative pneumonia. Langenbecks Arch Surg 391, 461–466 (2006). https://doi.org/10.1007/s00423-006-0089-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-006-0089-6